Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
16 September 2021 | Story Nonsindiso Qwabe | Photo Supplied
Dr Samantha Potgieter.

As COVID-19 vaccines continue to be a topical issue in South Africa and indeed in the world itself, the Department of Human Resources held a webinar for the UFS community on 10 September that delved deeper into the questions surrounding the vaccine. 

Dr Samantha Potgieter, infectious disease expert at the Universitas Academic Hospital and affiliated Lecturer in the Department of Internal Medicine at the University of the Free State, addressed some commonly raised concerns about the COVID-19 vaccine and how it affects us.

Dr Potgieter started off by saying that coronaviruses have been causing outbreaks among humans for millennia. While COVID-19 is relatively mild and self-limiting in 80% of patients, 20% of patients are at risk of developing severe disease.
She said before a vaccine could be introduced to a population, it had to go through rigorous testing and clinical trials. Only once safety has been confirmed, it can be released and distributed. 

“This process usually takes about ten years; this is what we are used to. But it has happened much quicker for the COVID-19 vaccine, and I think this is a fact that many people misinterpret – that the evidence might not be that robust, which is certainly not the case. COVID-19 vaccines have gone through all this rigorous testing, thousands of patients had volunteered for trial testing studies. The point is that we already had the technology, vaccination is not something new to humans. So, these preclinical trials were able to happen very quickly, and because of the large number of infections and because the focus of the entire world was on finding a cure, it was a very set process to get these trials through the adequate phases.” 

She said the COVID-19 vaccine was approved by national regulators, manufactured to exacting standards, and only thereafter distributed – as is the case for all drugs released into the market.

How does the vaccine work?

Dr Potgieter said the vaccine works by producing antibodies against the COVID-19 virus. If you are infected with the COVID-19 virus after getting vaccinated, these antibodies bind to the virus and stop it from replicating.

“When you get infected with a disease such as COVID-19, natural antibodies are produced by the immune system to fight the disease. If you get infected again, the immune system will remember how to respond, and quickly destroy the virus. A vaccine can do the same, but without the risk of disease from natural infection. Vaccines work by imitating a bacteria or virus using either mRNA in the case of the COVID-19 vaccine, or a dead or weakened version of the bacteria or virus. The vaccine raises the body’s alarm. It trains the body to recognise and fight the virus. When the body encounters the real-deal virus, it is primed and ready to fight for the body’s health.”

She said South Africa had the mRNA vaccine in the form of the Pfizer vaccine, and the adenoviral vector vaccine in the form of the Johnson & Johnson vaccine.

Why should you get the vaccine?

Dr Potgieter said vaccines are safe and effective, and the most compelling reasons for getting vaccinated are the following:

-To protect yourself from severe disease
-To protect those around you who may be at risk of severe disease
-To restore the social and economic platforms of the country, and the world at large.
She said that while the vaccine does not prevent you from getting COVID-19, it offers better protection against the development of severe disease, and vaccinated people had 50% less chance of spreading the virus.
The most common side effects of the vaccine are the following:
-Pain at the injection site
-Swollen lymph nodes
-Fever
-Fatigue
-Headache
-Myalgia (muscle pain)

“These are indications that the immune system is mounting a response. When it mounts a response, it produces antibodies,” she said.

Answers to commonly asked questions are the following:

1. Can the vaccine alter my DNA?
“No, it goes nowhere near the nucleus of the cell.”

2. What happens when you get COVID in between the first and second doses?
“Some protection is conferred after the first dose, but maximum protection is conferred two weeks after the second dose. Vaccination is still advised.” 

Dr Potgieter said patients who were between vaccinations still show better recovery results than those without.

3. What about natural immunity?
“Natural immunity might confer better protection, but it runs the risk of severe disease. Yes, immunity can be gained through natural immunity, it can be gained through vaccination, and it can certainly be gained by a combination of the two.”

4. What about long-term side effects?
“Serious side effects that cause long-term health problems following any vaccination are very rare, including the COVID-19 vaccination.”

To get the answers to more of your questions, the webinar can be accessed via the following link: https://event.webinarjam.com/go/replay/43/053q6a8vay9a0qa2

News Archive

Students excel in legal interpreting programme
2010-02-24

Prof. Ezekiel Moraka, Vice-Rector: External Relations at the UFS with one of the students who received a diploma.
Photo: Mangaliso Radebe


A success rate of 90% was achieved by the first group of 100 students that successfully completed the two-year Diploma in Legal Interpreting at the University of the Free State (UFS).

The group recently received their diplomas at the ceremony held on the Main Campus in Bloemfontein.

The programme, offered by the university’s Department of Afroasiatic Studies, Sign Language and Language Practice, in collaboration with the Department of Justice and Constitutional Development and Safety and Security Sector Education and Training Authority (SASSETA), is the only one of its kind in South Africa.

“The numbers that we are talking about here, if one looks at the needs of the country as such, is a small fraction,” said Advocate Simon Jiyane, Deputy Director General: Court Services in the Department of Justice.

“This is our first programme in collaboration with the UFS and I am hopeful it will lay a very solid foundation for other such programmes to follow.”

The diplomas were conferred by Prof. Ezekiel Moraka, Vice-Rector: External Relations at the UFS, on behalf of the Rector and Vice-Chancellor, Prof. Jonathan Jansen.

He urged the students to use their skills as qualified court interpreters in the context of the challenges that face South Africa such as HIV/Aids, racism, transformation, unemployment, poverty, job losses, and many other such challenges.

“This is the reality we are faced with, all of us,” he said. “It requires skilful and morally upright people to address it adequately and effectively. You are adding up to the number of skilful people in our country and that means you have a critical role to play.”

He said the UFS, as a societal structure, is equally affected by those challenges because of being accountable to and economically dependent on society.

He also urged the students to use their skills to make contributions to the processes of transformation that are underway at the UFS.

“For instance, the UFS as a national asset has to transform to that level of being a true national asset. We need your full participation in this process so that we can together ensure the relevance of this university as a true South African university,” he said.

Advocate Jiyane urged universities to also look at some of the initiatives that the government takes to improve service delivery. One such initiative is a pilot project focusing on the use of indigenous languages in courts.

“Its aim is to ensure that our courts begin to recognise all official languages in terms of conducting their business,” he said.

“It is our responsibility as a department that, through this project, we begin to build those languages so that they are on a par with the other languages that are being utilised in our courts.”

The department has permanently employed two of the students who received their diplomas, while one of them, Ms Nombulelo Esta Meki, was awarded a bursary by SASSETA to study for a BA in Legal Interpreting. Ms Meki was the top achiever of the programme with an average of 86%.

Media Release:
Mangaliso Radebe
Assistant Director: Media Liaison
Tel: 051 401 2828
Cell: 078 460 3320
E-mail: radebemt@ufs.ac.za  
3 March 2010

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept